News

Regulatory NewsRegulatory Round-up - April 2024
Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2024202320222021 →
Jim Faulkner, Nicole Mather and Carolyn Porter join the Cell and Gene Therapy Catapult as Non-Executive DirectorsJim Faulkner, Nicole Mather and Carolyn Porter join the Cell and Gene Therapy Catapult as Non-Executive DirectorsNew projects aim to improve environmental sustainability of the cell and gene therapy industryNew projects aim to improve environmental sustainability of the cell and gene therapy industryRegulatory Round-up - March 2024Regulatory Round-up - March 2024Standing out: Defining the market for your new ATMP assetStanding out: Defining the market for your new ATMP asset£17.9m for Advanced Therapy Treatment Centre network to bolster clinical trial infrastructure in the UK: NIHR, Innovate UK and CGT Catapult align strategically to further improve patient access and the UK’s leadership£17.9m for Advanced Therapy Treatment Centre network to bolster clinical trial infrastructure in the UK: NIHR, Innovate UK and CGT Catapult align strategically to further improve patient access and the UK’s leadershipRegulatory Round-up - February 2024Regulatory Round-up - February 2024Braintree Manufacturing Innovation Centre receives MHRA licence to manufacture advanced therapiesBraintree Manufacturing Innovation Centre receives MHRA licence to manufacture advanced therapiesAn effective team strategy for cell and gene therapy venturesAn effective team strategy for cell and gene therapy venturesEducation Secretary joins Cell and Gene Therapy Catapult to celebrate apprenticesEducation Secretary joins Cell and Gene Therapy Catapult to celebrate apprenticesRegulatory Round-up - January 2024Regulatory Round-up - January 2024UK maintains its position as an attractive destination for advanced therapy clinical trialsUK maintains its position as an attractive destination for advanced therapy clinical trialsCell and Gene Therapy Catapult announces successful renewal of its five-year funding from Innovate UK to further support the advanced therapies sectorCell and Gene Therapy Catapult announces successful renewal of its five-year funding from Innovate UK to further support the advanced therapies sector